A retrospective study to evaluate the efficacy and safety profile of rivaroxaban following hip and knee arthroplasty.
Phase of Trial: Phase IV
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 30 Jul 2015 New trial record
- 14 Jun 2015 Interim Results (n=99) presented at the 20th Congress of the European Haematology Association.